Depression

Excessive Use of Social Media During COVID-19 Outbreak Predicted Depression
While social media was rewarding to many users looking for informational, emotional, and peer support when the COVID-19 pandemic hit, excessive use led to mental health issues, according to a study published in Computers in Human Behavior.
Zuranolone Improves Depressive Symptoms Within 14 Days
Zuranolone, an investigational neuroactive steroid, improved depressive symptoms in a majority of patients within a 14-day treatment course, topline results from an ongoing phase 3 open-label study show.
Targeted Exposure to Stress Can Improve Depressive Symptoms
Introducing time-limited adaptive stressors has demonstrated a profound effect on patient well-being, but efforts to sidestep stress often overshadow these approaches in today's society, Psych Congress 2020 cochair Charles Raison, MD, said at the…
Simple Solutions Can Help Providers Manage Side Effects
In managing side effects associated with psychotropic drugs, prescribers need to arm themselves with a menu of strategies and opt first for simpler solutions over adding or switching a medication, Rajnish Mago, MD, said at Psych Congress 2020.
Linked EHR, Claims Data Provide Glimpse of Real-World Antidepressant Adherence
Patients with major depressive disorder had significantly lower odds of filling a written prescription for a new antidepressant if they were nonwhite and antidepressant-naïve, according to an investigation presented in a poster at Psych Congress…
Psychedelics Bring Patients Face-to-Face with Underlying Issues
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
Adjunctive Brexpiprazole Enhances Calming, Engagement in MDD
Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.
Daily Social Media Use Does Not Raise Depression Risk in Teens
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
Using Inflammatory Biomarkers to Guide Depression Treatment Choices
Psych Congress 2020 cochair Charles Raison, MD, discusses the role of inflammatory biomarkers in guiding depression treatment choices.
Combining Ketamine With Psychotherapy to Treat Depression
A session being presented at Psych Congress 2020 will educate attendees on the practice of combining ketamine treatment with psychotherapy for patients with treatment-resistant depression (TRD).
Dr. Michael Thase Answers Your Questions on Depression Treatments
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.

Audio

Dr. Rakesh Jain Gives an Update on Glutamate
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
ABC News Podcast Features Psych Congress Faculty
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
A Discussion on the Science of Depression
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top